N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease
Neurobiology of Disease · 2026
DOI: 10.1016/j.nbd.2026.107485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Esther Del Cid-Pellitero und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Fondation canadienne pour l'innovation, Canada Research Chairs Program.
Abstract (Originalsprache)
α-synuclein protein is a major constituent of pathological intracellular inclusions such as Lewy bodies found in brains of patients with Parkinson's disease and other synucleinopathies. Whereas α-synuclein phosphorylation has been much studied, comparatively less work has been devoted to other post-translational modifications such as acetylation, especially given that N-terminally acetylated α-synuclein is the most abundant endogenous form of the protein in the brain. In this study, using multiple in vitro and in vivo models of Parkinson's disease, we sought to understand the pathological consequences of N-terminally acetylated α-synuclein. We found that N-terminal acetylation slowed aggregation of both α-synuclein monomers and pre-formed fibrils in seed amplification assay. Uptake of acetylated pre-formed fibrils into both immortalized cell lines and iPSC-derived dopamine neurons was slowed compared to non-acetylated fibrils. In addition, exposure to acetylated pre-formed fibrils induced less seeding of endogenous α-synuclein, as measured by the accumulation of serine129-phosphorylated α-synuclein inclusions in both iPSC-derived dopamine neurons and mice brains. Finally, mice injected with N-terminally acetylated α-synuclein pre-formed fibrils survived significantly longer than mice injected with non-acetylated fibrils. Taken together, our study indicates that N-terminal acetylation reduces α-synuclein aggregation, uptake into cells, seeding of endogenous α-synuclein, and toxicity in vivo, suggesting that this prevalent post-translational modification represents a potent, physiologically relevant protective mechanism, which has thus far largely not been taken into consideration in most experimental paradigms of Parkinson's disease and synucleinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada.
- Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, Canada; The Neuro's Early Drug Discovery Unit (EDDU), Montreal Neurological Institute, McGill…
- Department of Pharmacology & Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, QC, Canada.
Förderung
- Canadian Institutes of Health Research
- Fondation canadienne pour l'innovation
- Canada Research Chairs Program
- Quebec Health Research Fund
- Parkinson Society Canada
- Fonds de recherche du Québec
Zitieren
APA
Del Cid-Pellitero, E., Goiran, T., Al-Azzawi, Z. A. M., Karpilovsky, N. C., Jones-Tabah, J., Mayo, J. J., Larroquette, F., Luo, W., Shlaifer, I., Thattikota, Y., Bayne, A., Trempe, J. F., Durcan, T. M., & Fon, E. A. (2026). N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107485
Vancouver
Del Cid-Pellitero E, Goiran T, Al-Azzawi ZAM, Karpilovsky NC, Jones-Tabah J, Mayo JJ, et al. N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107485
BibTeX
@article{DelCidPellitero2026,
author = {Del Cid-Pellitero, Esther and Goiran, Thomas and Al-Azzawi, Zaid A M and Karpilovsky, Nathan C and Jones-Tabah, Jace and Mayo, Jonas J and Larroquette, Frederique and Luo, Wen and Shlaifer, Irina and Thattikota, Yogitha and Bayne, Andrew and Trempe, Jean-Francois and Durcan, Thomas M and Fon, Edward A},
title = {N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease},
journal = {Neurobiology of Disease},
year = {2026},
doi = {10.1016/j.nbd.2026.107485}
}
EUVIMED